We have four research and development
programs investigating treatments for asthma/allergy, rheumatoid arthritis,
oncology and hepatitis C. Rigel does not undertake any obligation
to update forward -looking statements. The technology
portfolio includes web-based portal solutions and tracking tools , Interactive
Voice Response Systems (IVRS), Clinical Trial Management Systems (CTMS),
electronic diary and investigator database solutions.com)
Rigel's mission is to become a source of novel , small-molecule drugs to
address large, unmet medical needs.

conducts treatments

Rigel to Present at 5th Annual Fortis Bank Biotech Conference on April 27 2005

Gower, Rigel's chairman
and chief executive officer , will discuss the company's clinical development
and research programs. ET on
Thursday, April 27, 2006 to discuss the results.

u facilitate

periodontal resource

With a commitment to providing
solutions that expedite time-to -market and peak market penetration, PAREXEL
has developed significant expertise in clinical trials management, data
management, biostatistical analysis, medical marketing, clinical pharmacology,
regulatory and medical consulting, industry training and publishing and other
drug development consulting services . Its information technology subsidiary,
Perceptive Informatics, Inc. PAREXEL's integrated services , therapeutic area depth and
sophisticated information technology, along with its experience in global drug
development and product launch services, represent key competitive strengths.com/rigel/events .

consultant dental

, Rigel
Pharmaceuticals, Inc.

SOUTH SAN FRANCISCO, Calif.

About Rigel (http://www. Any statements contained in this press release that are not
statements of historical fact may be deemed to be forward-looking statements.

technical conducts

m.m. To participate via
telephone, dial (612 ) 332-0819 and ask to join PAREXEL's Third Quarter
conference call.

Rigel to Present at the Lehman Brothers Eighth Annual Global Healthcare Conference on March 31 2005

Gower, Rigel's chairman and
chief executive officer is scheduled to present a corporate overview at the
Lehman Brothers Eighth Annual Global Healthcare Conference on Thursday, March
31, 2005 at 5:15 p.

u consulting

Double-click the microphone labeled "Third
Quarter Earnings Conference Call" to begin. This webcast will continue to be
accessible for one year following the live broadcast., develops and offers a portfolio of innovative
technology -based products and services that facilitate clinical drug
development and are designed to decrease time to peak sales.rigel.

nose trade

healthcare dental

This press release contains "forward-looking" statements, including
statements related to Rigel's plans to pursue clinical development of product
candidates and the timing thereof and the potential efficacy of product
candidates. The event will be held at the Loews Hotel in Miami Beach
from March 30-April 1.

efficacy field

parexel. Perceptive also offers
advanced medical diagnostics services to assess rapidly and objectively the
safety and efficacy of new drugs, biologics, and medical devices in clinical
trials. Our strategy is to initiate clinical trials with at
least one new product candidate annually and to pursue partnerships with
pharmaceutical and biotechnology companies for late-stage clinical development
and commercialization of those product candidates.

This press release contains "forward-looking" statements, including
statements related to Rigel 's plans to pursue clinical development of product
candidates and the timing thereof and the potential efficacy of product
candidates.

efficacy libya

Headquartered near Boston, MA, PAREXEL operates in 51 locations throughout 39
countries around the world, and has approximately 5,360 employees.

m.

clinical technical

(Nasdaq: RIGL) -- James M. We have four research and development
programs investigating treatments for asthma /allergy, rheumatoid arthritis,
hepatitis C and oncology.
Words such as "plans," "intends," "expects " and similar expressions are
intended to identify these forward-looking statements.

evaluation individuals

dental safety

About Rigel (http://www.rigel.

evaluation trials

com.

PAREXEL is a registered trademark of PAREXEL International Corporation,
and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. Please connect to Rigel's website several
minutes prior to the start of the conference call to ensure adequate time for
any software download that may be necessary.

evaluation trade

James M.com and on the PR Newswire website at
http: //www.

PAREXEL is one of the largest biopharmaceutical outsourcing organizations
in the world, providing a broad range of knowledge-based contract research,
medical marketing and consulting services to the worldwide pharmaceutical,
biotechnology and medical device industries. All
other names or marks may be registered trademarks or trademarks of their
respective owners and are hereby acknowledged.

clinical safety

parexel.

clinical trade

Our strategy is to initiate clinical trials with at
least one new product candidate annually and to pursue partnerships with
pharmaceutical and biotechnology companies for late-stage clinical development
and commercialization of those product candidates. To access the webcast, visit
PAREXEL's website at http://www. Rigel does not undertake any obligation
to update forward-looking statements.

resource treatments

com, click on the Investor Relations
menu and select "Webcasts". There are a number of
important factors that could cause Rigel's results to differ materially from
those indicated by these forward-looking statements, including risks
associated with the timing and success of clinical trials and the
commercialization of product candidates, as well as other risks detailed from
time to time in Rigel's SEC reports, including its Annual Report on Form 10-K
for the year ended December 31, 2004.

trials treatments

com)
Rigel's mission is to become a source of novel, small-molecule drugs to
address large, unmet medical needs.

dental clinical

Words such as "plans," "intends," "expects" and similar expressions are
intended to identify these forward-looking statements.

PAREXEL Announces Date of Third Quarter Earnings Release and Conference Call

BOSTON, PAREXEL International
Corporation (Nasdaq: PRXL) will release Third Quarter Fiscal Year 2006
financial results on Wednesday, April 26, 2006 after the close of the stock
market. The announcement will be available on PAREXEL's website at
http://www.

conducts treatments

field facilitate

(Nasdaq: RIGL) will present at the 5th Annual Fortis
Bank Biotech Conference on Wednesday , April 27, 2005 at 10:00 a., Rigel
Pharmaceuticals, Inc.
To access the live audio webcast or the subsequent archived recording, log
on to http://www.

halitosis trials

SOUTH SAN FRANCISCO, Calif.rigel. Any statements contained in this press release that are not
statements of historical fact may be deemed to be forward-looking statements. There are a number of
important factors that could cause Rigel 's results to differ materially from
those indicated by these forward-looking statements, including risks
associated with the timing and success of clinical trials and the
commercialization of product candidates, as well as other risks detailed from
time to time in Rigel's SEC reports, including its Annual Report on Form 10-K
for the year ended December 31, 2004.

conducts field

British
Time at the Four Seasons Hotel in London.prnewswire.
PAREXEL will host a conference call and live webcast at 11:00 a.

universal treatments

---

- - kjjkjk

Loading...

(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)